Failure of primaquine therapy for the treatment of Plasmodium ovale malaria [3]

Clinical Infectious Diseases

Volumn 41, Issue 10, 2005, Pages 1544-1545

  Bottieau, Emmanuel ^a   Van Gompel, Alfons ^a   Peetermans, Willy E ^b  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DOXYCYCLINE; MEFLOQUINE; PRIMAQUINE; QUININE;

ADOLESCENT; ADULT; BLOOD SMEAR; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; LETTER; MALARIA; MALE; NONHUMAN; PATIENT COMPLIANCE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PRIORITY JOURNAL; RELAPSE; TREATMENT FAILURE;

ADOLESCENT; ADULT; ANTIMALARIALS; HUMANS; MALARIA; MALE; PLASMODIUM OVALE; PRIMAQUINE; RECURRENCE; TREATMENT FAILURE;

EID: 27644544933     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/497378     Document Type: Letter

References (5)

1. Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis 2004; 39:1336-45.
2. Nathwani D, Currie PF, Smith CC, Khaund R. Recurrent Plasmodium ovale infection from Papua New Guinea-chloroquine resistance or inadequate primaquine therapy? J Infect 1991; 23:343-4.
3. Rombo L, Edwards G, Ward SA, et al. Seven patients with relapses of Plasmodium vivax or P. ovale despite primaquine treatment. Trop Med Parasitol 1987; 38:49-50.
4. Spudick JM, Garcia LS, Graham DM, Haake DA. Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax. J Clin Microbiol 2005; 43:978-81.
5. Centers for Disease Control and Prevention. Treatment for malaria: guidelines for clinicians, part 2-general approach and uncomplicated malaria. Available at: http://www.cdc.gov/ma laria/diagnosis_treatment/clinicians2.htm. Accessed 27 July 2005.